Financial Statements

AbbVie Inc. (ABBV)

$182.1

+1.75 (+0.97%)

Balance Sheet Statement

All numbers are in thousands
Year XLSX
2023
XLSX
2022
XLSX
2021
XLSX
2020
XLSX
2019
Total assets 134,711,000138,805,000146,529,000150,565,00089,115,000
Total Current Assets 33,002,00028,463,00027,928,00024,173,00049,519,000
Cash and Short Term Investments 12,816,0009,229,0009,830,0008,479,00039,924,000
Cash and cash equivalents 12,814,0009,201,0009,746,0008,449,00039,924,000
Short Term Investments 2,00028,00084,00030,000-
Receivables 11,155,00011,254,0009,977,0008,822,0005,428,000
Inventory 4,099,0003,579,0003,128,0003,310,0001,813,000
Other Current Assets 4,932,0004,401,0004,993,0003,562,0002,354,000
Total non-current Assets 101,709,000110,342,000118,601,000126,392,00039,596,000
Property, Plant & Equipment Net 4,989,0004,935,0005,110,0005,248,0002,962,000
Goodwill and Intangible Assets 87,903,00099,595,000108,330,000116,000,00034,253,000
Goodwill 87,903,00099,595,000108,330,000116,000,00034,253,000
Intangible Assets 55,610,00067,439,00075,951,00082,876,00018,649,000
Long Term Investments 304,000241,000277,000293,00093,000
Other non-current Assets 6,561,0003,381,0001,875,0001,205,0001,158,000
Total liabilities 124,314,000121,518,000131,093,000137,468,00097,287,000
Total current liabilities 37,841,00029,538,00035,194,00028,661,00015,585,000
Payables 3,688,0002,934,0002,882,0002,276,0001,452,000
Short Term debt 7,191,0004,136,00012,495,0008,502,0003,753,000
Deferred revenue -3,688,000----
Other Current Liabilities 30,650,00022,468,00019,817,00017,883,00010,380,000
Total non-current liabilities 86,473,00091,980,00095,899,000108,807,00081,702,000
Long Term debt 52,194,00059,135,00064,189,00077,554,00062,975,000
Other non-current Liabilities 28,607,00030,655,00022,106,00020,347,00011,195,000
Total shareholders equity 10,360,00017,254,00015,408,00013,076,000-8,172,000
Common Stock 18,00018,00018,00018,00018,000
Retained earnings -1,000,0004,784,0003,127,0001,055,0004,717,000
Accumulated Other Comprehensive Income Loss -2,305,000-2,199,000-2,899,000-3,117,000-3,596,000
Other Stockholders Equity 13,647,00014,651,00015,162,00015,120,000-9,311,000
Total debt 59,385,00063,271,00076,684,00086,056,00066,728,000
Total Investments 306,000269,000361,000323,00093,000
Net Debt 46,571,00054,070,00066,938,00077,607,00026,804,000

AbbVie Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AbbVie Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.